Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by G1945Von Feb 03, 2023 1:14pm
133 Views
Post# 35265287

CEO.CA @Yoyo

CEO.CA @Yoyo@Yoyo Everyone here needs to calm down abit. These processes take time.. VPT has only really been at the sales process for about 6 months post covid.. covid wrote off most of 2021 and 2022 as hospitals were recovering from the backlog of in person appt’s and surgeries. I was fortunate enough to speak with GA a few weeks back and asked the tough questions. My main take aways, which I believe will put some investors at ease here is that the last 6/6 demos ended up in purchases. Thats a 100% conversion rate. He mentioned that they had another 10 demo’s scheduled, which will also hopefully all lead to purchases. He also states they have 30+ demo requests they need to schedule. The issue with booking a demo is that it takes weeks/ months to get the head dr, nurses, buyers etc all to coordinate a day thats convenient for them all.. the actual demo and instal only takes a day. Theres lots of moving parts to account for. When asked about NICE, he reiterated it was a low end clerical error, and we should hopefully see the new version sometime in Feb. the UK distributor expects phone to ring off the hook once the report is out..by the sounds of it we are well underway to hit the 80-100 sales number which proves to the big boys that the tech is real, theres a need and theres money in it… once that number is hit the buyout talks can get very serious. I know its been a long wait for everyone including myself, but its all in the works to make us very, very happy if we can wait a couple more months IMO.


G1945V

<< Previous
Bullboard Posts
Next >>